Bognar B, Spohn R, Lazar V
NPJ Antimicrob Resist. 2025; 2(1):29.
PMID: 39843924
PMC: 11721080.
DOI: 10.1038/s44259-024-00047-2.
Dunster E, Johnson W, Wozniak R
Cornea. 2023; 42(12):1555-1561.
PMID: 37106486
PMC: 10611897.
DOI: 10.1097/ICO.0000000000003304.
Lazar V, Snitser O, Barkan D, Kishony R
Nature. 2022; 610(7932):540-546.
PMID: 36198788
PMC: 9533972.
DOI: 10.1038/s41586-022-05260-5.
Raja F, Worthington T, de Souza L, Hanaei S, Martin R
ACS Biomater Sci Eng. 2022; 8(3):1193-1199.
PMID: 35199992
PMC: 9007416.
DOI: 10.1021/acsbiomaterials.1c00876.
Danis-Wlodarczyk K, Cai A, Chen A, Gittrich M, Sullivan M, Wozniak D
Pharmaceuticals (Basel). 2021; 14(11).
PMID: 34832944
PMC: 8624478.
DOI: 10.3390/ph14111162.
Understanding tolerance to cell wall-active antibiotics.
Dorr T
Ann N Y Acad Sci. 2020; 1496(1):35-58.
PMID: 33274447
PMC: 8359209.
DOI: 10.1111/nyas.14541.
Phage-Antibiotic Combination Treatments: Antagonistic Impacts of Antibiotics on the Pharmacodynamics of Phage Therapy?.
Abedon S
Antibiotics (Basel). 2019; 8(4).
PMID: 31614449
PMC: 6963693.
DOI: 10.3390/antibiotics8040182.
A Multidisciplinary Study to Evaluate the Anti-quorum Sensing Ability of Phyto-compounds in Jacq.
Chemmugil P, Lakshmi P, Annamalai A
Avicenna J Med Biotechnol. 2019; 11(1):48-58.
PMID: 30800243
PMC: 6359695.
A Mechanism of Synergistic Effect of Streptomycin and Cefotaxime on CTX-M-15 Type β-lactamase Producing Strain of A First Report.
Maryam L, Khan A
Front Microbiol. 2016; 7:2007.
PMID: 28018328
PMC: 5156679.
DOI: 10.3389/fmicb.2016.02007.
AZDAST the new horizon in antimicrobial synergism detection.
Ziaei-Darounkalaei N, Ameri M, Zahraei-Salehi T, Ziaei-Darounkalaei O, Mohajer-Tabrizi T, Bornaei L
MethodsX. 2016; 3:43-52.
PMID: 27408829
PMC: 4929268.
DOI: 10.1016/j.mex.2016.01.002.
The innate growth bistability and fitness landscapes of antibiotic-resistant bacteria.
Deris J, Kim M, Zhang Z, Okano H, Hermsen R, Groisman A
Science. 2013; 342(6162):1237435.
PMID: 24288338
PMC: 4059556.
DOI: 10.1126/science.1237435.
The pharmaco -, population and evolutionary dynamics of multi-drug therapy: experiments with S. aureus and E. coli and computer simulations.
Ankomah P, Johnson P, Levin B
PLoS Pathog. 2013; 9(4):e1003300.
PMID: 23593006
PMC: 3617031.
DOI: 10.1371/journal.ppat.1003300.
[Not Available].
Bull World Health Organ. 2010; 28 Suppl:100-14.
PMID: 20604153
PMC: 2554624.
Evaluating aztreonam and ceftazidime pharmacodynamics with Escherichia coli in combination with daptomycin, linezolid, or vancomycin in an in vitro pharmacodynamic model.
LaPlante K, Sakoulas G
Antimicrob Agents Chemother. 2009; 53(10):4549-55.
PMID: 19620335
PMC: 2764192.
DOI: 10.1128/AAC.00180-09.
CHLORAMPHENICOL.
Brock T
Bacteriol Rev. 1961; 25(1):32-48.
PMID: 16350168
PMC: 441072.
DOI: 10.1128/br.25.1.32-48.1961.
Studies on antibiotic synergism and antagonism. Synergism among seven antibiotics against various bacteria in vitro.
JEWETZ E, GUNNISON J, BRUFF J, COLEMAN V
J Bacteriol. 1952; 64(1):29-39.
PMID: 14946096
PMC: 169686.
DOI: 10.1128/JB.64.1.29-39.1952.
Modern use of urinary antiseptics.
HINMAN Jr F
Calif Med. 1952; 76(1):1-7.
PMID: 14886751
PMC: 1521195.
SPORES OF MICROORGANISMS. XIV. LATE STAGES OF INTRASPORANGIAL DEVELOPMENT OF BACTERIAL SPORES: THEIR SENSITIVITY TO ANTIBIOTICS.
Vinter V
Folia Microbiol (Praha). 1964; 18:58-72.
PMID: 14149845
DOI: 10.1007/BF02868786.
Induction of bacterial lysis by penicillin.
PRESTIDGE L, Pardee A
J Bacteriol. 1957; 74(1):48-59.
PMID: 13462959
PMC: 289881.
DOI: 10.1128/jb.74.1.48-59.1957.
[Studies of the effect of combined penicillin and aureomycin on staphylococci].
Ritzerfeld W
Z Hyg Infektionskr. 1956; 143(3):247-60.
PMID: 13401973
